Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Gallstones and incident colorectal cancer in a large pan-European cohort study.

Ward HA, Murphy N, Weiderpass E, Leitzmann MF, Aglago E, Gunter MJ, Freisling H, Jenab M, Boutron-Ruault MC, Severi G, Carbonnel F, Kühn T, Kaaks R, Boeing H, Tjønneland A, Olsen A, Overvad K, Merino S, Zamora-Ros R, Rodríguez-Barranco M, Dorronsoro M, Chirlaque MD, Barricarte A, Perez-Cornago A, Trichopoulou A, Bamia C, Lagiou P, Masala G, Grioni S, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita B, Vermeulen R, Van Gils C, Nyström H, Rutegård M, Aune D, Riboli E, Cross AJ.

Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32090. [Epub ahead of print]

PMID:
30585640
2.

Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study.

Baumeister SE, Schlesinger S, Aleksandrova K, Jochem C, Jenab M, Gunter MJ, Overvad K, Tjønneland A, Boutron-Ruault MC, Carbonnel F, Fournier A, Kühn T, Kaaks R, Pischon T, Boeing H, Trichopoulou A, Bamia C, La Vecchia C, Masala G, Panico S, Fasanelli F, Tumino R, Grioni S, Bueno de Mesquita B, Vermeulen R, May AM, Borch KB, Oyeyemi SO, Ardanaz E, Rodríguez-Barranco M, Dolores Chirlaque López M, Felez-Nobrega M, Sonestedt E, Ohlsson B, Hemmingsson O, Werner M, Perez-Cornago A, Ferrari P, Stepien M, Freisling H, Tsilidis KK, Ward H, Riboli E, Weiderpass E, Leitzmann MF.

J Hepatol. 2018 Dec 22. pii: S0168-8278(18)32633-3. doi: 10.1016/j.jhep.2018.12.014. [Epub ahead of print]

PMID:
30582978
3.

Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study.

Meyer A, Rudant J, Drouin J, Weill A, Carbonnel F, Coste J.

Ann Intern Med. 2019 Jan 15;170(2):99-107. doi: 10.7326/M18-1512. Epub 2018 Dec 11.

PMID:
30534946
4.

Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors.

de Malet A, Antoni G, Collins M, Soularue E, Marthey L, Vaysse T, Coutzac C, Chaput N, Mateus C, Robert C, Carbonnel F.

Eur J Cancer. 2019 Jan;106:106-114. doi: 10.1016/j.ejca.2018.10.006. Epub 2018 Nov 23.

PMID:
30476730
5.

Networks meet ulcerative colitis.

Carbonnel F.

Lancet Gastroenterol Hepatol. 2018 Nov;3(11):730-731. doi: 10.1016/S2468-1253(18)30283-8. No abstract available.

PMID:
30353851
6.

Towards more efficient assessment of ulcerative colitis drugs.

Carbonnel F.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):8-9. doi: 10.1016/S2468-1253(18)30342-X. Epub 2018 Oct 18. No abstract available.

PMID:
30343115
7.

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Pellet G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, Roblin X, Allimant C, Nachury M, Nancey S, Filippi J, Altwegg R, Brixi H, Fotsing G, de Rosamel L, Shili S, Laharie D; Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):494-501. doi: 10.1016/j.cgh.2018.08.081. Epub 2018 Sep 10.

PMID:
30213584
8.

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy.

Collins M, Pellat A, Antoni G, Agostini H, Labeyrie C, Adams D, Carbonnel F.

PLoS One. 2018 Aug 30;13(8):e0201869. doi: 10.1371/journal.pone.0201869. eCollection 2018.

9.

Enterocolitis due to immune checkpoint inhibitors: a systematic review.

Soularue E, Lepage P, Colombel JF, Coutzac C, Faleck D, Marthey L, Collins M, Chaput N, Robert C, Carbonnel F.

Gut. 2018 Nov;67(11):2056-2067. doi: 10.1136/gutjnl-2018-316948. Epub 2018 Aug 21. Review.

PMID:
30131322
10.

Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort.

Matejcic M, Lesueur F, Biessy C, Renault AL, Mebirouk N, Yammine S, Keski-Rahkonen P, Li K, Hémon B, Weiderpass E, Rebours V, Boutron-Ruault MC, Carbonnel F, Kaaks R, Katzke V, Kuhn T, Boeing H, Trichopoulou A, Palli D, Agnoli C, Panico S, Tumino R, Sacerdote C, Quirós JR, Duell EJ, Porta M, Sánchez MJ, Chirlaque MD, Barricarte A, Amiano P, Ye W, Peeters PH, Khaw KT, Perez-Cornago A, Key TJ, Bueno-de-Mesquita HB, Riboli E, Vineis P, Romieu I, Gunter MJ, Chajès V.

Int J Cancer. 2018 Nov 15;143(10):2437-2448. doi: 10.1002/ijc.31797. Epub 2018 Sep 21.

PMID:
30110135
11.

Patient, Procedure, and Endoscopist Risk Factors for Perforation, Bleeding, and Splenic Injury After Colonoscopies.

Laanani M, Coste J, Blotière PO, Carbonnel F, Weill A.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):719-727.e13. doi: 10.1016/j.cgh.2018.08.005. Epub 2018 Aug 9.

12.

Drug-induced coma after chemotherapy in intensive care unit: How to make the right diagnosis?

Boilève A, Osman D, Marthey L, Carbonnel F, Jozwiak M.

J Neurol Sci. 2018 Sep 15;392:137-138. doi: 10.1016/j.jns.2018.07.015. Epub 2018 Jul 21. No abstract available.

PMID:
30059846
13.

Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study.

Murphy N, Ward HA, Jenab M, Rothwell JA, Boutron-Ruault MC, Carbonnel F, Kvaskoff M, Kaaks R, Kühn T, Boeing H, Aleksandrova K, Weiderpass E, Skeie G, Borch KB, Tjønneland A, Kyrø C, Overvad K, Dahm CC, Jakszyn P, Sánchez MJ, Gil L, Huerta JM, Barricarte A, Quirós JR, Khaw KT, Wareham N, Bradbury KE, Trichopoulou A, La Vecchia C, Karakatsani A, Palli D, Grioni S, Tumino R, Fasanelli F, Panico S, Bueno-de-Mesquita B, Peeters PH, Gylling B, Myte R, Jirström K, Berntsson J, Xue X, Riboli E, Cross AJ, Gunter MJ.

Clin Gastroenterol Hepatol. 2018 Jul 26. pii: S1542-3565(18)30756-0. doi: 10.1016/j.cgh.2018.07.030. [Epub ahead of print]

14.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Haanen JBAG, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv264-iv266. doi: 10.1093/annonc/mdy162. No abstract available.

PMID:
29917046
15.

Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Zamora-Ros R, Cayssials V, Jenab M, Rothwell JA, Fedirko V, Aleksandrova K, Tjønneland A, Kyrø C, Overvad K, Boutron-Ruault MC, Carbonnel F, Mahamat-Saleh Y, Kaaks R, Kühn T, Boeing H, Trichopoulou A, Valanou E, Vasilopoulou E, Masala G, Pala V, Panico S, Tumino R, Ricceri F, Weiderpass E, Lukic M, Sandanger TM, Lasheras C, Agudo A, Sánchez MJ, Amiano P, Navarro C, Ardanaz E, Sonestedt E, Ohlsson B, Nilsson LM, Rutegård M, Bueno-de-Mesquita B, Peeters PH, Khaw KT, Wareham NJ, Bradbury K, Freisling H, Romieu I, Cross AJ, Vineis P, Scalbert A.

Eur J Epidemiol. 2018 Nov;33(11):1063-1075. doi: 10.1007/s10654-018-0408-6. Epub 2018 May 15.

16.

A prospective evaluation of plasma polyphenol levels and colon cancer risk.

Murphy N, Achaintre D, Zamora-Ros R, Jenab M, Boutron-Ruault MC, Carbonnel F, Savoye I, Kaaks R, Kühn T, Boeing H, Aleksandrova K, Tjønneland A, Kyrø C, Overvad K, Quirós JR, Sánchez MJ, Altzibar JM, María Huerta J, Barricarte A, Khaw KT, Bradbury KE, Perez-Cornago A, Trichopoulou A, Karakatsani A, Peppa E, Palli D, Grioni S, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita HBA, Peeters PH, Rutegård M, Johansson I, Freisling H, Noh H, Cross AJ, Vineis P, Tsilidis K, Gunter MJ, Scalbert A.

Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31563. [Epub ahead of print]

17.

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R.

Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.

PMID:
29655835
18.

Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis in European Populations: A Nested Case-Control Study.

Opstelten JL, Chan SSM, Hart AR, van Schaik FDM, Siersema PD, Lentjes EGWM, Khaw KT, Luben R, Key TJ, Boeing H, Bergmann MM, Overvad K, Palli D, Masala G, Racine A, Carbonnel F, Boutron-Ruault MC, Tjønneland A, Olsen A, Andersen V, Kaaks R, Kühn T, Tumino R, Trichopoulou A, Peeters PHM, Verschuren WMM, Witteman BJM, Oldenburg B.

Inflamm Bowel Dis. 2018 Feb 15;24(3):633-640. doi: 10.1093/ibd/izx050.

PMID:
29462382
19.

Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.

Butt J, Jenab M, Willhauck-Fleckenstein M, Michel A, Pawlita M, Kyrø C, Tjønneland A, Boutron-Ruault MC, Carbonnel F, Severi G, Kaaks R, Kühn T, Boeing H, Trichopoulou A, la Vecchia C, Karakatsani A, Panico S, Tumino R, Agnoli C, Palli D, Sacerdote C, Bueno-de-Mesquita HBA, Weiderpass E, Sánchez MJ, Bonet Bonet C, Huerta JM, Ardanaz E, Bradbury K, Gunter M, Murphy N, Freisling H, Riboli E, Tsilidis K, Aune D, Waterboer T, Hughes DJ.

Int J Cancer. 2018 Jul 15;143(2):245-252. doi: 10.1002/ijc.31283. Epub 2018 Feb 14.

20.

Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD).

Andersen V, Chan S, Luben R, Khaw KT, Olsen A, Tjonneland A, Kaaks R, Grip O, Bergmann MM, Boeing H, Hultdin J, Karling P, Overvad K, Oldenburg B, Opstelten J, Boutron-Ruault MC, Carbonnel F, Racine A, Key T, Masala G, Palli D, Tumino R, Trichopoulou A, Riboli E, Hart A.

J Crohns Colitis. 2018 Jan 24;12(2):129-136. doi: 10.1093/ecco-jcc/jjx136.

21.

Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit.

Urbina T, Belkhir R, Rossi G, Carbonnel F, Pavy S, Collins M, Mariette X, Seror R.

J Bone Miner Res. 2018 Mar;33(3):540-542. doi: 10.1002/jbmr.3369. Epub 2018 Feb 7. No abstract available.

22.

Connected Health Devices for Health Care in French General Medicine Practice: Cross-Sectional Study.

El Amrani L, Oude Engberink A, Ninot G, Hayot M, Carbonnel F.

JMIR Mhealth Uhealth. 2017 Dec 21;5(12):e193. doi: 10.2196/mhealth.7427.

23.

Significance of Immune-related Lipase Increase Induced by Antiprogrammed Death-1 or Death Ligand-1 Antibodies: A Brief Communication.

Michot JM, Ragou P, Carbonnel F, Champiat S, Voisin AL, Mateus C, Lambotte O, Annereau M.

J Immunother. 2018 Feb/Mar;41(2):84-85. doi: 10.1097/CJI.0000000000000202.

PMID:
29252914
24.

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.

Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R.

JAMA. 2017 Nov 7;318(17):1679-1686. doi: 10.1001/jama.2017.16071.

25.

Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Dec 4;11(12):1512. doi: 10.1093/ecco-jcc/jjx105. No abstract available.

PMID:
29088340
26.

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies.

Collins M, Michot JM, Danlos FX, Mussini C, Soularue E, Mateus C, Loirat D, Buisson A, Rosa I, Lambotte O, Laghouati S, Chaput N, Coutzac C, Voisin AL, Soria JC, Marabelle A, Champiat S, Robert C, Carbonnel F.

Ann Oncol. 2017 Nov 1;28(11):2860-2865. doi: 10.1093/annonc/mdx403.

PMID:
29045560
27.

Raising Awareness About Cervical Cancer Using Twitter: Content Analysis of the 2015 #SmearForSmear Campaign.

Lenoir P, Moulahi B, Azé J, Bringay S, Mercier G, Carbonnel F.

J Med Internet Res. 2017 Oct 16;19(10):e344. doi: 10.2196/jmir.8421.

28.

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

Coutzac C, Adam J, Soularue E, Collins M, Racine A, Mussini C, Boselli L, Kamsukom N, Mateus C, Charrier M, Cassard L, Planchard D, Ribrag V, Fizazi K, Loriot Y, Lepage P, Scoazec JY, Robert C, Carbonnel F, Chaput N.

J Crohns Colitis. 2017 Oct 1;11(10):1238-1246. doi: 10.1093/ecco-jcc/jjx081.

PMID:
28967957
29.

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, Pozdzik A, Labauge P, Palat S, Berthelot JM, Pennaforte JL, Wynckel A, Lebas C, Le Gouellec N, Quémeneur T, Dahan K, Carbonnel F, Leroux G, Perlat A, Mathian A, Cacoub P, Hachulla E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N.

PLoS One. 2017 Sep 15;12(9):e0183844. doi: 10.1371/journal.pone.0183844. eCollection 2017.

30.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Haanen JBAG, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K; ESMO Guidelines Committee.

Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142. doi: 10.1093/annonc/mdx225. No abstract available.

PMID:
28881921
31.

Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).

Lu Y, Zamora-Ros R, Chan S, Cross AJ, Ward H, Jakszyn P, Luben R, Opstelten JL, Oldenburg B, Hallmans G, Karling P, Grip O, Key T, Bergmann MM, Boeing H, Overvad K, Palli D, Masala G, Khaw KT, Racine A, Carbonnel F, Boutron-Ruault MC, Andersen V, Olsen A, Tjonneland A, Kaaks R, Tumino R, Trichopoulou A, Scalbert A, Riboli E, Hart AR.

Inflamm Bowel Dis. 2017 Dec;23(12):2072-2082. doi: 10.1097/MIB.0000000000001108.

32.

Diet and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort.

Barré A, Gusto G, Cadeau C, Carbonnel F, Boutron-Ruault MC.

Am J Gastroenterol. 2017 Sep;112(9):1448-1456. doi: 10.1038/ajg.2017.216. Epub 2017 Jul 25.

PMID:
28741614
33.

Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan-authors'reply.

Marthey L, Carbonnel F.

Aliment Pharmacol Ther. 2017 Aug;46(4):473-474. doi: 10.1111/apt.14191. No abstract available.

34.

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.

Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, Portela F, Peixoto A, Szilagyi A, Silva M, Maconi G, Har-Noy O, Bossuyt P, Mantzaris G, Barreiro de Acosta M, Chaparro M, Christodoulou DK, Eliakim R, Rahier JF, Magro F, Drobne D, Ferrante M, Sonnenberg E, Siegmund B, Muls V, Thurm T, Yanai H, Dotan I, Raine T, Levin A, Israeli E, Ghalim F, Carbonnel F, Vermeire S, Ben-Horin S, Roblin X.

Inflamm Bowel Dis. 2017 Sep;23(9):1605-1613. doi: 10.1097/MIB.0000000000001160.

PMID:
28590343
35.

Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies.

Nimptsch K, Song M, Aleksandrova K, Katsoulis M, Freisling H, Jenab M, Gunter MJ, Tsilidis KK, Weiderpass E, Bueno-De-Mesquita HB, Chong DQ, Jensen MK, Wu C, Overvad K, Kühn T, Barrdahl M, Melander O, Jirström K, Peeters PH, Sieri S, Panico S, Cross AJ, Riboli E, Van Guelpen B, Myte R, Huerta JM, Rodriguez-Barranco M, Quirós JR, Dorronsoro M, Tjønneland A, Olsen A, Travis R, Boutron-Ruault MC, Carbonnel F, Severi G, Bonet C, Palli D, Janke J, Lee YA, Boeing H, Giovannucci EL, Ogino S, Fuchs CS, Rimm E, Wu K, Chan AT, Pischon T.

Eur J Epidemiol. 2017 May;32(5):419-430. doi: 10.1007/s10654-017-0262-y. Epub 2017 May 26.

36.

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors.

Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, Pallardy M, Carbonnel F, Spindeldreher S, Mariette X, Miceli-Richard C, Maillère B.

Front Immunol. 2017 May 5;8:500. doi: 10.3389/fimmu.2017.00500. eCollection 2017.

37.

Incidence, Phenotype, and Mortality of Inflammatory Bowel Disease 'Twenty Years After'.

Carbonnel F, Boutron MC.

J Crohns Colitis. 2017 Oct 1;11(10):1159-1160. doi: 10.1093/ecco-jcc/jjx072. No abstract available.

PMID:
28525593
38.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009. No abstract available.

PMID:
28513805
39.

A rolling phenotype in Crohn's disease.

Irwin J, Ferguson E, Simms LA, Hanigan K, Carbonnel F, Radford-Smith G.

PLoS One. 2017 Apr 6;12(4):e0174954. doi: 10.1371/journal.pone.0174954. eCollection 2017.

40.

No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC).

Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR.

Eur J Clin Nutr. 2017 Apr;71(4):566. doi: 10.1038/ejcn.2017.16. No abstract available.

PMID:
28377581
41.

Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.

Fedirko V, Tran HQ, Gewirtz AT, Stepien M, Trichopoulou A, Aleksandrova K, Olsen A, Tjønneland A, Overvad K, Carbonnel F, Boutron-Ruault MC, Severi G, Kühn T, Kaaks R, Boeing H, Bamia C, Lagiou P, Grioni S, Panico S, Palli D, Tumino R, Naccarati A, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Castaño JM, Barricarte A, Sánchez MJ, Dorronsoro M, Quirós JR, Agudo A, Sjöberg K, Ohlsson B, Hemmingsson O, Werner M, Bradbury KE, Khaw KT, Wareham N, Tsilidis KK, Aune D, Scalbert A, Romieu I, Riboli E, Jenab M.

BMC Med. 2017 Apr 4;15(1):72. doi: 10.1186/s12916-017-0830-8.

42.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, Vaysse T, Marthey L, Eggermont A, Asvatourian V, Lanoy E, Mateus C, Robert C, Carbonnel F.

Ann Oncol. 2017 Jun 1;28(6):1368-1379. doi: 10.1093/annonc/mdx108.

PMID:
28368458
43.

No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC).

Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR.

Eur J Clin Nutr. 2017 Apr;71(4):512-518. doi: 10.1038/ejcn.2016.271. Epub 2017 Jan 25. Erratum in: Eur J Clin Nutr. 2017 Apr;71(4):566.

44.

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hébuterne X, Abitbol V, Nachury M, Brixi H, Bourreille A, Picon L, Bourrier A, Allez M, Peyrin-Biroulet L, Moreau J, Savoye G, Fumery M, Nancey S, Roblin X, Altwegg R, Bouguen G, Bommelaer G, Danese S, Louis E, Zappa M, Mary JY; GETAID CREOLE Study Group.

Gut. 2018 Jan;67(1):53-60. doi: 10.1136/gutjnl-2016-312581. Epub 2017 Jan 24.

45.

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Moussata D, Allez M, Cazals-Hatem D, Treton X, Laharie D, Reimund JM, Bertheau P, Bourreille A, Lavergne-Slove A, Brixi H, Branche J, Gornet JM, Stefanescu C, Moreau J, Marteau P, Pelletier AL, Carbonnel F, Seksik P, Simon M, Fléjou JF, Colombel JF, Charlois AL, Roblin X, Nancey S, Bouhnik Y, Berger F, Flourié B; the GETAID.

Gut. 2018 Apr;67(4):616-624. doi: 10.1136/gutjnl-2016-311892. Epub 2017 Jan 23.

PMID:
28115492
46.

IgG4-Related Disease in Monozygotic Twins: A Case Report.

Grados A, Vaysse T, Ebbo M, Carbonnel F, Schleinitz N.

Ann Intern Med. 2017 Jan 17;166(2):153-155. doi: 10.7326/L16-0122. No abstract available.

PMID:
28114468
47.

Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?

Carbonnel F, Soularue E, Coutzac C, Chaput N, Mateus C, Lepage P, Robert C.

Semin Immunopathol. 2017 Apr;39(3):327-331. doi: 10.1007/s00281-016-0613-x. Epub 2017 Jan 16. Review.

PMID:
28093620
48.

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Bommelaer G, Coffin B, Roblin X, van Assche G, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, de Vos M, Lambert J, Mary JY, Louis E; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Gut. 2018 Feb;67(2):237-243. doi: 10.1136/gutjnl-2016-313060. Epub 2017 Jan 4.

49.

Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.

Kirchgesner J, Lemaitre M, Rudnichi A, Racine A, Zureik M, Carbonnel F, Dray-Spira R.

Aliment Pharmacol Ther. 2017 Jan;45(1):37-49. doi: 10.1111/apt.13835. Epub 2016 Oct 26.

50.

The accuracy of preoperative imaging in measuring the length of the ileocolic segment affected by Crohn's disease: a prospective cohort study.

Brouquet A, Rangheard AS, Ifergan J, Lazure T, Carbonnel F, Penna C, Benoist S.

Colorectal Dis. 2017 May;19(5):437-445. doi: 10.1111/codi.13502.

PMID:
27607894

Supplemental Content

Loading ...
Support Center